Paul M Hassoun

Committed to excellence in scholarship on pulmonary and critical care medicine, Dr. Paul M. Hassoun is a distinguished Professor of Medicine at Johns Hopkins University. With a specialized focus on pulmonary hypertension, Dr. Hassoun leads the pulmonary hypertension program at Johns Hopkins Hospital, where he applies his extensive research experience to advance understanding and treatment of pulmonary arterial hypertension. Dr. Hassoun's research interests are deeply rooted in the regulation and role of pulmonary hypertension and acute lung injury. His work has significantly contributed to the field, providing insights into the mechanisms and potential therapeutic approaches for these complex conditions. His dedication to research is matched by his commitment to patient care, ensuring that his findings translate into improved outcomes for those affected by pulmonary diseases. Throughout his career, Dr. Hassoun has been an active member of various professional committees and has held numerous leadership roles in prestigious organizations related to pulmonary medicine. His leadership and expertise have been instrumental in shaping policies and advancing the field, reflecting his commitment to both scientific inquiry and clinical excellence. Dr. Hassoun's contributions have been recognized through numerous awards and honors, underscoring his impact on the field of pulmonary medicine. His work not only enhances the scientific community's understanding of pulmonary conditions but also inspires the next generation of researchers and clinicians. In addition to his research and clinical duties, Dr. Hassoun is dedicated to mentoring students and young professionals, fostering an environment of learning and innovation. His passion for teaching and mentorship is evident in his interactions with students, colleagues, and patients alike. Dr. Hassoun continues to push the boundaries of pulmonary research, driven by a desire to improve patient care and outcomes. His ongoing projects and collaborations reflect his commitment to advancing the field and addressing the challenges posed by pulmonary hypertension and acute lung injury.